Authors
Archana Mishra, Rituparna Maiti, Tathagata Biswas, Biswa R Mishra
Published in
The journal of ECT. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Obsessive-compulsive (OC) symptoms are prevalent in patients with schizophrenia and may be exacerbated by clozapine, the cornerstone pharmacotherapy for treatment-resistant schizophrenia (TRS). Electroconvulsive therapy (ECT) is an established augmentation strategy in TRS; however, its impact on comorbid OC symptoms in this population has not been systematically described. We report a case series of 5 patients with TRS maintained on clozapine who exhibited prominent OC symptoms. All patients underwent a course of ECT. Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS) and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at baseline (week 0) and at weeks 2 and 6. All 5 patients demonstrated substantial improvement in both psychotic symptoms (PANSS) and OC symptoms (Y-BOCS) over 6 weeks of follow-up. The median reduction was 78.3% for Y-BOCS (range: 50.0% to 80.0%) compared with 24.3% for PANSS (range: 22.5% to 65.4%; n = 3), suggesting marked remission of OC symptoms. ECT may selectively ameliorate OC symptoms arising in the context of TRS or clozapine use, possibly through distinct neurobiological mechanisms not operative in primary OCD. Further controlled studies are warranted, as this contrasts with the known lack of efficacy of ECT in primary OCD.
PMID:
43044036
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0